Dr Pavan Kumar C G

Consultant Surgical Oncologist, Robotic & Advanced Laparoscopic Cancer Surgeon

MBBS, MS, MCh (Surgical Oncology), Fellowship in Minimal access Surgical Oncology

Medical Council Registration No : KMC105845

Book An Appointment

+91 9130056215

drpavankumarcg@gmail.com

Department of Surgical Oncology, Manjushree block, SDM Dharwad

Book An Appointment

Specializations

Expertised In

Robotic surgery

Advanced Laparoscopic Cancer Surgery

About

Dr. Pavan Kumar C. G.

Dr. Pavan Kumar C. G. is an experienced cancer surgeon who specializes in advanced cancer treatments. He completed his MBBS at Bangalore Medical College, MS in General Surgery at Government Medical College in Nagpur, and MCh in Surgical Oncology at AIIMS Bhubaneswar. He also trained in Robotic Surgery and Advanced Laparoscopic Surgery at Fortis Bangalore.

 

Dr. Pavan is currently working in the Department of Surgical Oncology at SDM Dharwad, providing expert cancer care.

He is skilled in performing advanced surgeries, including robotic procedures, laparoscopic techniques, Video-Assisted Thoracic Surgery (VATS), and endoscopic operations like thyroid and lymph node surgeries. Dr. Pavan believes that every patient is unique and deserves a treatment plan tailored to their specific needs. By considering factors like age, gender, lifestyle, and individual responses, he offers personalized care. His key focus areas include Gastrointestinal Cancer, Gynecological Cancer, Breast Cancer, Oral Cancer, and Soft Tissue Tumors, along with specialized treatments like HIPEC (a form of chemotherapy).

Dr. Pavan Kumar is dedicated to using modern surgical methods and a patient-centered approach to deliver the best possible outcomes for his patients.

 

Contact Dr. Pavan Kumar C. G. today for more details and personalized cancer care.

Qualification

• Fellowship in Minimally Invasive Surgical Oncology (Robotic Surgery and Advanced Laparoscopy)

Fortis Hospital, Bangalore (September 2023 – September 2024)

• MCh in Surgical Oncology

All india Institute of Medical Sciences, Bhubaneswar, Odisha, India (August 2020 – September 2023)

• MS in General Surgery

Government Medical College, Nagpur, Maharashtra, India (2015 – 2018)

• MBBS

Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India (2008 – 2014)

Experience

• Consultant Surgical Oncologist

SDM Dharwad (October 2024 – Present)

• Senior Fellow in Minimally Invasive Surgical Oncology (Robotic Surgery and Advanced Laparoscopy)

Fortis Hospital, Bangalore (September 2023 – September 2024)

• Senior Resident (Surgical Oncology)

AIIMS Bhubaneswar, Odisha (September 2020 – August 2023)

• Senior Resident (General Surgery)

East Point Medical College, Bangalore, Karnataka (August 2019 – July 2020)

• Senior Medical Officer (General Surgery)

Cooper Hospital, Mumbai (August 2018 – July 2019)

Areas Of Expertise

• Gastrointestinal Oncology
• Gynecological Oncology, including HIPEC procedures
• Breast Cancer treatment including Breast conservation surgeries, sentinel lymph node biopsy and oncoplastic breast surgeries
• Oral Malignancies
• Soft Tissue Tumors

Membership

• Member, Indian Association of Surgical Oncology (IASO)
• Member, Odisha Society of Oncology
• Member, Odisha Society of Surgical Oncology

Testimonials

What Our Patients Say

I was really scared after my cancer diagnosis, but Dr. Pavan explained everything clearly and supported me at every step. His care and skill in surgery helped me recover faster than I expected. I’m so thankful to him.

Ravi

Patient

Dr. Pavan treated me with advanced laparoscopic surgery for my stomach cancer. He was very professional and caring, and the surgery went perfectly. I feel healthy again, all thanks to him!

Kaveri

Patient

Dr. Pavan was so kind and patient when I came to him for breast cancer treatment. He listened to all my concerns and made sure I understood my options. His treatment plan worked so well, and I couldn’t be happier with the results.

Madhura

Patient

FAQ

Frequently Asked Questions

Q1. What are the benefits of laparoscopy and robotic surgery?

Laparoscopy and robotic surgery offer several advantages over traditional open cancer surgery, including:

 

• Reduced pain and discomfort
• Minimal blood loss and fewer transfusions
• Lower risk of complications
• Shorter hospital stays
• Reduced infection risk
• Faster recovery and return to daily activities.

Q2. What is robotic cancer surgery?

Robotic cancer surgery, performed using the "Da Vinci" robot, is a minimally invasive procedure. The surgeon operates from a monitor displaying HD images of internal organs and controls robotic arms inserted through small incisions.

Q3. Is robotic surgery painful?

Robotic surgery is painless during the procedure due to anesthesia. Post-surgery, discomfort is usually mild and managed with pain medication.

Q4. What is laparoscopy cancer surgery?

Laparoscopy and robotic cancer surgery, also called Minimal Access Surgery (MACS), are minimally invasive procedures used mainly for early-stage cancers. A small incision is made to insert a laparoscope, an instrument with an attached camera that provides clear images of internal organs on an external monitor, avoiding the large cuts of open surgery.

Latest

View All

05 Nov 2025

Operated Cases

Retroperitoneal Liposarcoma Surgery | Dr Pavan Kumar

Operating on sarcomas continues to be one of the most rewarding experiences for a surgical oncologist. Each case demands not only technical mastery but also deep respect for complex anatomy and multidisciplinary collaboration.

Recently, a 50-year-old woman presented with a large retroperitoneal liposarcoma, posing considerable anatomical and technical challenges. Managing such tumors requires meticulous preoperative planning and precise intraoperative execution.

Such cases truly test a surgeon’s anatomical understanding, operative skill, and patience — qualities that lie at the very heart of complex oncologic surgery.

The surgery was successfully completed with complete tumor excision, and the patient made a smooth postoperative recovery, being discharged happily in stable condition.

These experiences reaffirm the joy and fulfillment of surgical oncology — where precision, perseverance, and teamwork come together to deliver meaningful recovery and hope for our patients.

Read More

28 Sep 2025

Health Tips

ESOPEC Trial Review in Esophageal Cancer | Dr Pavan Kumar

The ESOPEC trial (NEJM 2025) is a landmark phase III study directly comparing perioperative FLOT chemotherapywith neoadjuvant CROSS chemoradiotherapy in resectable esophageal and gastroesophageal junction adenocarcinoma.

✅ Key findings:

Median OS: 66 months (FLOT) vs 37 months (CROSS)

5-year OS: 50.6% vs 38.7%

PFS benefit: HR 0.66 (95% CI 0.51–0.85)

Distinct recurrence and toxicity patterns between arms

Take-home message:
FLOT is the new standard for adenocarcinoma, while CROSS remains pivotal for squamous cell carcinoma.

📺 I’ve broken down the methodology, outcomes, strengths, and limitations of ESOPEC in detail on my YouTube channel – Journal Club Oncology. 👉 Watch the full Journal Club discussion on YouTube:
https://youtu.be/aleVBk9PbbU

Read More

21 Sep 2025

Health Tips

PORTEC-3 Trial 10-Year Results | Journal Club Oncology | Dr Pavan Kumar

The PORTEC-3 trial continues to shape our understanding of adjuvant therapy in high-risk endometrial cancer. With updated 10-year follow-up data, it provides valuable insights into survival outcomes and the role of molecular classification in guiding treatment.

🔑 Key Highlights

Chemoradiotherapy vs Radiotherapy Alone
Long-term benefit in overall survival (OS) and recurrence-free survival (RFS) persists with combined modality treatment.

p53-abnormal (p53-abn) tumors
Patients derive a substantial survival advantage with chemoradiotherapy.

POLE-mutated cancers
Show an excellent prognosis regardless of treatment, supporting treatment de-escalation in this subgroup.

MMR-deficient (MMRd) & NSMP groups
Outcomes highlight the need for immunotherapy approaches and further risk stratification in these subsets.

 

🎥 Watch my detailed discussion on this trial and its clinical implications on my Journal Club Oncology channel: 👉 PORTEC-3 Trial Discussion – Dr. Pavan Kumar

 

 

Read More

View All